CD69 Association with Jak3/Stat5 Proteins Regulates Th17 Cell Differentiation
Loading...
Download
Official URL
Full text at PDC
Publication date
2010
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor & Francis
Citation
Martín, Pilar, et al. «CD69 Association with Jak3/Stat5 Proteins Regulates Th17 Cell Differentiation». Molecular and Cellular Biology, vol. 30, n.o 20, octubre de 2010, pp. 4877-89. https://doi.org/10.1128/MCB.00456-10.
Abstract
T-cell differentiation involves the early decision to commit to a particular pattern of response to an antigen. Here, we show that the leukocyte activation antigen CD69 limits differentiation into proinflammatory helper T cells (Th17 cells). Upon antigen stimulation in vitro, CD4+ T cells from CD69-deficient mice generate an expansion of Th17 cells and the induction of greater mRNA expression of interleukin 17 (IL-17), IL 23 receptor (IL-23R), and the nuclear receptor retinoic acid-related orphan receptor γt (RORγt). In vivo studies with CD69-deficient mice bearing OTII T-cell receptors (TCRs) specific for OVA peptide showed a high proportion of antigen-specific Th17 subpopulation in the draining lymph nodes, as well as in CD69-deficient mice immunized with type II collagen. Biochemical analysis demonstrated that the CD69 cytoplasmic tail associates with the Jak3/Stat5 signaling pathway, which regulates the transcription of RORγt and, consequently, differentiation toward the Th17 lineage. Functional experiments in Th17 cultures demonstrated that the selective inhibition of Jak3 activation enhanced the transcription of RORγt. Moreover, the addition of exogenous IL-2 restored Stat5 phosphorylation and inhibited the enhanced Th17 differentiation in CD69-deficient cells. These results support the early activation receptor CD69 as an intrinsic modulator of the T-cell differentiation program that conditions immune inflammatory processes.
Description
This work was supported by grant SAF2008-02719 from the Spanish Ministry of Science and Innovation to P.M.; grant PI06/0937 from ISCIII-MSC to M.G.; and grants SAF2008-02635 from the Spanish Ministry of Science and Innovation, RECAVA [RD06/0014-0030] from the Instituto de Salud Carlos III, MEICA from the Genoma España Foundation, and INSINET 01592006 from Comunidad de Madrid to F.S.-M. P.M. is an investigator for the Spanish Ministry of Science and Innovation Ramón y Cajal Program (RYC-2006). The CNIC is supported by the Ministry of Science and Innovation and the Pro CNIC Foundation.